M James Mock's Insider Trades & SAST Disclosures
M James Mock's most recent trade in Moderna Inc was a trade of 63,478 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Feb. 28, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern M James Mock.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Moderna Inc | James M Mock | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 63,478 | 63,478 | - | - | Stock Option (Right to Buy) | |
| Moderna Inc | James M Mock | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 39,606 | 39,606 | - | - | Restricted Stock Units | |
| Moderna Inc | James M Mock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 329 | 15,034 (0%) | 0% | - | Common Stock | |
| Moderna Inc | James M Mock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 329 | 2,630 | - | - | Restricted Stock Units | |
| Moderna Inc | James M Mock | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 31.09 per share. | 28 Feb 2025 | 160 | 14,874 (0%) | 0% | 31.1 | 4,974 | Common Stock |
| Moderna Inc | James M Mock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2025 | 3,094 | 9,283 | - | - | Restricted Stock Units | |
| Moderna Inc | James M Mock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2025 | 3,094 | 15,517 (0%) | 0% | - | Common Stock | |
| Moderna Inc | James M Mock | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 33.58 per share. | 27 Feb 2025 | 1,496 | 14,021 (0%) | 0% | 33.6 | 50,236 | Common Stock |
| Moderna Inc | James M Mock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2025 | 1,326 | 13,065 (0%) | 0% | - | Common Stock | |
| Moderna Inc | James M Mock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2025 | 1,326 | 0 | - | - | Restricted Stock Units | |
| Moderna Inc | James M Mock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2025 | 1,326 | 0 | - | - | Performance Stock Units | |
| Moderna Inc | James M Mock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2025 | 1,326 | 15,347 (0%) | 0% | - | Common Stock | |
| Moderna Inc | James M Mock | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 33.58 per share. | 27 Feb 2025 | 642 | 14,705 (0%) | 0% | 33.6 | 21,558 | Common Stock |
| Moderna Inc | James M Mock | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 33.58 per share. | 27 Feb 2025 | 642 | 12,423 (0%) | 0% | 33.6 | 21,558 | Common Stock |
| Moderna Inc | James M Mock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2025 | 1,453 | 12,519 (0%) | 0% | - | Common Stock | |
| Moderna Inc | James M Mock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2025 | 1,453 | 10,169 | - | - | Restricted Stock Units | |
| Moderna Inc | James M Mock | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 42.00 per share. | 03 Jan 2025 | 780 | 11,739 (0%) | 0% | 42 | 32,760 | Common Stock |
| Moderna Inc | James M Mock | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Dec 2024 | 188,761 | 188,761 | - | - | Restricted Stock Units | |
| Moderna Inc | James M Mock | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 42.79 per share. | 27 Nov 2024 | 1,420 | 11,066 (0%) | 0% | 42.8 | 60,761 | Common Stock |
| Moderna Inc | James M Mock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Nov 2024 | 1,326 | 1,326 | - | - | Restricted Stock Units | |
| Moderna Inc | James M Mock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Nov 2024 | 1,326 | 1,326 | - | - | Performance Stock Units | |
| Moderna Inc | James M Mock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Nov 2024 | 1,326 | 12,486 (0%) | 0% | - | Common Stock | |
| Moderna Inc | James M Mock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Nov 2024 | 1,326 | 10,831 (0%) | 0% | - | Common Stock | |
| Moderna Inc | James M Mock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Nov 2024 | 329 | 2,959 | - | - | Restricted Stock Units | |
| Moderna Inc | James M Mock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Nov 2024 | 329 | 11,160 (0%) | 0% | - | Common Stock | |
| Moderna Inc | James M Mock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Oct 2024 | 1,453 | 11,622 | - | - | Restricted Stock Units | |
| Moderna Inc | James M Mock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Oct 2024 | 1,453 | 10,220 (0%) | 0% | - | Common Stock | |
| Moderna Inc | James M Mock | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 60.12 per share. | 04 Oct 2024 | 715 | 9,505 (0%) | 0% | 60.1 | 42,986 | Common Stock |
| Moderna Inc | James M Mock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Aug 2024 | 329 | 3,288 | - | - | Restricted Stock Units | |
| Moderna Inc | James M Mock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Aug 2024 | 329 | 8,929 (0%) | 0% | - | Common Stock | |
| Moderna Inc | James M Mock | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 78.02 per share. | 28 Aug 2024 | 162 | 8,767 (0%) | 0% | 78.0 | 12,640 | Common Stock |
| Moderna Inc | James M Mock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Aug 2024 | 1,326 | 8,595 (0%) | 0% | - | Common Stock | |
| Moderna Inc | James M Mock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Aug 2024 | 1,326 | 2,652 | - | - | Restricted Stock Units | |
| Moderna Inc | James M Mock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Aug 2024 | 1,326 | 2,652 | - | - | Performance Stock Units | |
| Moderna Inc | James M Mock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Aug 2024 | 1,326 | 9,921 (0%) | 0% | - | Common Stock | |
| Moderna Inc | James M Mock | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 79.40 per share. | 27 Aug 2024 | 1,321 | 8,600 (0%) | 0% | 79.4 | 104,881 | Common Stock |
| Moderna Inc | James M Mock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jul 2024 | 1,452 | 13,075 | - | - | Restricted Stock Units | |
| Moderna Inc | James M Mock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jul 2024 | 1,452 | 7,958 (0%) | 0% | - | Common Stock | |
| Moderna Inc | James M Mock | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 118.24 per share. | 05 Jul 2024 | 689 | 7,269 (0%) | 0% | 118.2 | 81,465 | Common Stock |
| Moderna Inc | James M Mock | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2024 | 5,304 | 5,304 | - | - | Performance Stock Units | |
| Moderna Inc | James M Mock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 May 2024 | 1,326 | 3,978 | - | - | Performance Stock Units | |
| Moderna Inc | James M Mock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 May 2024 | 1,326 | 7,197 (0%) | 0% | - | Common Stock | |
| Moderna Inc | James M Mock | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 140.72 per share. | 31 May 2024 | 691 | 6,506 (0%) | 0% | 140.7 | 97,237 | Common Stock |
| Moderna Inc | James M Mock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 May 2024 | 328 | 6,054 (0%) | 0% | - | Common Stock | |
| Moderna Inc | James M Mock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 May 2024 | 328 | 3,617 | - | - | Restricted Stock Units | |
| Moderna Inc | James M Mock | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 144.50 per share. | 28 May 2024 | 183 | 5,871 (0%) | 0% | 144.5 | 26,444 | Common Stock |
| Moderna Inc | James M Mock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 May 2024 | 1,326 | 6,374 (0%) | 0% | - | Common Stock | |
| Moderna Inc | James M Mock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 May 2024 | 1,326 | 3,978 | - | - | Restricted Stock Units | |
| Moderna Inc | James M Mock | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 162.47 per share. | 24 May 2024 | 648 | 5,726 (0%) | 0% | 162.5 | 105,283 | Common Stock |
| Moderna Inc | James M Mock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Apr 2024 | 1,453 | 5,753 (0%) | 0% | - | Common Stock | |
| Moderna Inc | James M Mock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Apr 2024 | 1,453 | 14,527 | - | - | Restricted Stock Units | |
| Moderna Inc | James M Mock | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 101.93 per share. | 05 Apr 2024 | 705 | 5,048 (0%) | 0% | 101.9 | 71,859 | Common Stock |
| Moderna Inc | James M Mock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2024 | 1,315 | 4,947 (0%) | 0% | - | Common Stock | |
| Moderna Inc | James M Mock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2024 | 1,315 | 3,945 | - | - | Restricted Stock Units | |
| Moderna Inc | James M Mock | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 94.57 per share. | 28 Feb 2024 | 647 | 4,300 (0%) | 0% | 94.6 | 61,188 | Common Stock |
| Moderna Inc | James M Mock | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2024 | 60,216 | 60,216 | - | - | Stock Option (Right to Buy) | |
| Moderna Inc | James Mock M | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2024 | 23,635 | 23,635 | - | - | Stock Option (Right to Buy) | |
| Moderna Inc | M James Mock | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2024 | 12,377 | 12,377 | - | - | Restricted Stock Units | |
| Moderna Inc | James M Mock | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2024 | 5,304 | 5,304 | - | - | Restricted Stock Units | |
| Moderna Inc | James Mock M | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2024 | 1,452 | 15,980 | - | - | Restricted Stock Units | |
| Moderna Inc | James M Mock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2024 | 1,452 | 4,404 (0%) | 0% | - | Common Stock | |
| Moderna Inc | Mock James M | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 109.76 per share. | 05 Jan 2024 | 772 | 3,632 (0%) | 0% | 109.8 | 84,731 | Common Stock |
| Moderna Inc | James M Mock | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2023 | 20,040 | 20,040 | - | - | Stock Option (Right to Buy) | |
| Moderna Inc | James M Mock | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2023 | 5,260 | 5,260 | - | - | Restricted Stock Units | |
| Moderna Inc | James M Mock | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Oct 2022 | 43,876 | 43,876 | - | - | Stock Option (Right to Buy) | |
| Moderna Inc | James M Mock | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Oct 2022 | 23,242 | 23,242 | - | - | Restricted Stock Units | |
| Revvity Inc. | James M Mock | Please See Remarks | Sale of securities on an exchange or to another person at price $ 145.78 per share. | 24 Jun 2022 | 2,290 | 28,240 (0%) | 0% | 145.8 | 333,836 | Common Stock |
| Revvity Inc. | James M Mock | Please See Remarks | Sale of securities on an exchange or to another person at price $ 144.90 per share. | 24 Jun 2022 | 2,072 | 30,530 (0%) | 0% | 144.9 | 300,233 | Common Stock |
| Revvity Inc. | James M Mock | Please See Remarks | Sale of securities on an exchange or to another person at price $ 146.34 per share. | 24 Jun 2022 | 663 | 27,577 (0%) | 0% | 146.3 | 97,023 | Common Stock |
| Revvity Inc. | James M Mock | Please See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2022 | 13,054 | 39,048 (0%) | 0% | 0 | Common Stock | |
| Revvity Inc. | James M Mock | Please See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2022 | 9,771 | 9,771 | - | - | NQ Stock Option (right to buy) | |
| Revvity Inc. | James M Mock | Please See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 182.95 per share. | 04 Feb 2022 | 4,998 | 34,050 (0%) | 0% | 182.9 | 914,384 | Common Stock |
| Revvity Inc. | James M Mock | Please See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2022 | 2,750 | 25,994 (0%) | 0% | 0 | Common Stock | |
| Revvity Inc. | James M Mock | Please See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 182.95 per share. | 04 Feb 2022 | 1,448 | 32,602 (0%) | 0% | 183.0 | 264,912 | Common Stock |
| Revvity Inc. | James M Mock | Please See Remarks | Sale of securities on an exchange or to another person at price $ 183.93 per share. | 20 Sep 2021 | 1,803 | 26,221 (0%) | 0% | 183.9 | 331,626 | Common Stock |
| Revvity Inc. | James M Mock | Please See Remarks | Sale of securities on an exchange or to another person at price $ 185.30 per share. | 20 Sep 2021 | 1,377 | 24,844 (0%) | 0% | 185.3 | 255,158 | Common Stock |
| Revvity Inc. | James M Mock | Please See Remarks | Sale of securities on an exchange or to another person at price $ 183.18 per share. | 20 Sep 2021 | 1,300 | 28,024 (0%) | 0% | 183.2 | 238,134 | Common Stock |
| Revvity Inc. | James M Mock | Please See Remarks | Sale of securities on an exchange or to another person at price $ 187.17 per share. | 20 Sep 2021 | 1,100 | 23,344 (0%) | 0% | 187.2 | 205,887 | Common Stock |
| Revvity Inc. | James M Mock | Please See Remarks | Sale of securities on an exchange or to another person at price $ 186.09 per share. | 20 Sep 2021 | 400 | 24,444 (0%) | 0% | 186.1 | 74,436 | Common Stock |
| Revvity Inc. | James M Mock | Please See Remarks | Sale of securities on an exchange or to another person at price $ 187.99 per share. | 20 Sep 2021 | 100 | 23,244 (0%) | 0% | 188.0 | 18,799 | Common Stock |
| Revvity Inc. | James M Mock | Please See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 143.50 per share. | 17 May 2021 | 4,005 | 29,324 (0%) | 0% | 143.5 | 574,718 | Common Stock |
| Revvity Inc. | James M Mock | Please See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 130.99 per share. | 06 Apr 2021 | 543 | 33,329 (0%) | 0% | 131.0 | 71,128 | Common Stock |
| Revvity Inc. | James M Mock | Please See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2021 | 11,125 | 11,125 | - | - | NQ Stock Option (right to buy) | |
| Revvity Inc. | James M Mock | Please See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2021 | 2,678 | 33,872 (0%) | 0% | 0 | Common Stock | |
| Revvity Inc. | James M Mock | Please See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2021 | 8,560 | 35,778 (0%) | 0% | 0 | Common Stock | |
| Revvity Inc. | James M Mock | Please See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 147.07 per share. | 01 Feb 2021 | 2,810 | 32,968 (0%) | 0% | 147.1 | 413,267 | Common Stock |
| Revvity Inc. | James M Mock | Please See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 147.07 per share. | 01 Feb 2021 | 1,774 | 31,194 (0%) | 0% | 147.1 | 260,902 | Common Stock |
| Revvity Inc. | James M Mock | Please See Remarks | Sale of securities on an exchange or to another person at price $ 124.58 per share. | 02 Oct 2020 | 4,423 | 27,318 (0%) | 0% | 124.6 | 551,017 | Common Stock |
| Revvity Inc. | James M Mock | Please See Remarks | Sale of securities on an exchange or to another person at price $ 123.69 per share. | 02 Oct 2020 | 1,100 | 31,741 (0%) | 0% | 123.7 | 136,059 | Common Stock |
| Revvity Inc. | James M Mock | Please See Remarks | Sale of securities on an exchange or to another person at price $ 125.08 per share. | 02 Oct 2020 | 100 | 27,218 (0%) | 0% | 125.1 | 12,508 | Common Stock |
| Revvity Inc. | James M Mock | Please See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 91.97 per share. | 15 May 2020 | 2,950 | 32,841 (0%) | 0% | 92.0 | 271,312 | Common Stock |
| Revvity Inc. | James M Mock | Please See Remarks | Grant, award, or other acquisition of securities at price $ 75.13 per share. | 06 Apr 2020 | 1,124 | 35,791 (0%) | 0% | 75.1 | 84,446 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges